Refine by MP, party, committee, province, or result type.

Results 1-6 of 6
Sorted by relevance | Sort by date: newest first / oldest first

Subcommittee on Neurological Disease committee  If I may, Mr. Chairman, I will just add that there are a few wrinkles in some of the arguments. First of all, my understanding is that Dr. Zamboni has distinctly said that his procedure does not work for progressive disease; it must be done on relapsing-remitting disease. The se

May 11th, 2010Committee meeting

Dr. Samuel Ludwin

Subcommittee on Neurological Disease committee  If I could just add, to continue, I actually am a great believer in spending money to do the studies as we requested the federal government do and as the National MS Society in the United States has done. I would make a plea, however, that these studies do get carried out before.

May 11th, 2010Committee meeting

Dr. Samuel Ludwin

Subcommittee on Neurological Disease committee  Certainly. What I would like to do is end up with what the importance of the CCSVI is. The CCSVI is an extraordinarily interesting, novel idea, and in fact the Multiple Sclerosis Society of Canada some time ago took a lead in the world in calling for a research proposal request,

May 11th, 2010Committee meeting

Dr. Samuel Ludwin

Subcommittee on Neurological Disease committee  Certainly. It would take a few days, though.

May 11th, 2010Committee meeting

Dr. Samuel Ludwin

Subcommittee on Neurological Disease committee  Thank you very much for inviting me to testify. My name is Samuel Ludwin. I'm a physician, a neuropathologist, which is somebody who studies the brain. I have been studying neuropathology for the last 40 years. During this period, although I look at all brain diseases in my cli

May 11th, 2010Committee meeting

Dr. Samuel Ludwin

Subcommittee on Neurological Disease committee  Yes. It's Dr. Ludwin. I'm hearing you loud and clear.

May 11th, 2010Committee meeting

Dr. Samuel Ludwin